CD86 Is an Activation Receptor for NK Cell Cytotoxicity against Tumor Cells

CTLA4Ig has been successfully used in the clinic for suppression of T cell activation. However, patients treated with CTLA4Ig experienced reduced incidence of tumors than predicted, but the underlying mechanism remains unknown. In this paper, we showed that brief administration of CTLA4Ig significan...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Peng, Yanmeng, Luo, Gaoxing, Zhou, Junyi, Wang, Xiaojuan, Hu, Jie, Cui, Yanyan, Li, Xian C., Tan, Jianglin, Yang, Sisi, Zhan, Rixing, Yang, Junjie, He, Weifeng, Wu, Jun
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3859666/
https://ncbi.nlm.nih.gov/pubmed/24349559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0083913
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items